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A simple, rapid, economic and green analytical method was validated for the determination of secnidazole in tablets. The aim was
to contribute to the green analytical chemistry since it has low use of organic solvent and low production of toxic waste. For the
HPLC-UV method, the mobile phase consisted in a mixture of purified water + 0.7 % acetic acid and ethanol (78:22, v/v) at a
flow rate of 1.3 mL min-1 on a CN Luna column (250 x 4.6 mm, 5 μm particle size). Ultraviolet detection was performed at 318
nm. The method was linear over the concentration range of 5-100 μg mL-1 (r = 0.9998) with limits of detection and quantitation of
0.533 e 1.615 μg mL-1, respectively. The precision of the method showed RSD less than 2 %. The accuracy determined by the
average  recoveries  was  99.58 %. The secnidazole  tablets  were  subjected  to  oxidation,  acid,  alkaline,  neutral  and  photolytic
degradation as stress conditions and the method was considered as indicative of stability. The method is adequate and safe to be a
great alternative in routine quality control analyzes for determination and quantification of secnidazole tablets.
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Introduction 
Secnidazole,  shown in Figure 1,  is chemically designated,
according  to  IUPAC,  as  (RS)  -1-  (2-methyl-5-nitro-1H-
imidazol-21-yl) propan-2-ol. Due it belongs to the group of
5-nitroimidazoles,  it  has  broad-spectrum  activity  against
anaerobic protozoa and many anaerobic and microaerophilic
bacteria  (1).  It  has  as  mechanism of  action  the  ability  to
penetrate  by  diffusion  in  the  microorganism  suffering
subsequent  reduction  in  its  nitro  group;  in  the  case  of
parasites,  the  reduction  occurs  by  the  pyruvate-ferridoxin
pathway, leading to drug activation (2).
                    
Figure 1. Chemical structure of secnidazole (CAS 3366-95-8).
The high performance liquid chromatography (HPLC) is an
analytical technique widely used in analytical laboratories of
chemical and pharmaceutical industries for routine analysis
of  the  quality  control  (3).  Among the  techniques  used  in
quality control, HPLC is a technique with major advantages
since  it  provides  faster  analysis,  better  resolution,  greater
sensitivity, detectability and precision (4). HPLC has been
used  to  determine  secnidazole  mostly  in  pharmaceutical
drugs (5-11) and in human blood (6, 12-13). In the literature,
green analytical methods for secnidazole by HPLC were not
found; moreover, the methods use large amount of organic
solvents  that  are  toxic  to  operators  and  the  environment.
Nowadays,  green  analytical  methods  are  relevant  and
advantageous  to  industries  because  it  brings  less
environmental  impacts,  low  analytical  costs  and  higher
operator  safety.  That  is  why  there  are  many  validated
physical-chemical  and  microbiological  methods  for  drugs
quantification  that  apply  the  concept  of  green  analytical
chemistry  to  help  in  the  environmental  preservation,
following  the  same  line  of  this  work  in  cases  of  HLPC
methods that use ethanol and water in the mobile phase (14-
21).
In the case of HPLC analysis, the use of ethanol instead of
solvents  such  as  methanol  and  acetonitrile  reduces  the
toxicity  to  the  analyst  and  generates  less  waste  to  the
environment. The toxicity reduction when ethanol is chosen
occurs  because  methanol  generates  toxic  metabolics  in
human body, as formaldehyde and formic acid, being a risk
to analyst due to daily exposure. Other important fact is that
ethanol generates residues that are easily removed, while the
acetonitrile, after being incinerated, forms nitrogen residues
that contribute to acid rain (22-23). In addition, the use of
ethanol and not of the buffer solution in the mobile phase
reduces  many  problems  caused  to  the  chromatographic
system, especially damage to the analytical column, where
the  inorganic  salts  interact  largely  with  silica  (24-26).
Thus, it was developed in this study a new analytical method
by  HPLC  focused  on  green  analytical  chemistry,  for
quantification of secnidazole in tablets, in order  to reduce
costs,  preserve  the  environment  and  greater  safety  of
operators.
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Experimental
Instrumentation and Reagents
Secnidazole  standard,  declared  content  of  99.63  %,  were
kindly  provided  by  the  EMS  pharmaceutical  company
(Hortolândia, SP, Brazil). Secnidazole in tablets containing
1000  mg  of  active  substance  were  used  as  samples.
All solutions and the mobile phase used in this method were
prepared  from ultrapure  water  (Millipore®,  Bedford,  MA,
USA).  HPLC grade  ethanol  (Panreac®,  Barcelona,  Spain)
and HPLC grade acetic acid (J.T. Baker®, Phillipsburg, NJ,
USA) were used in the mobile phase. After preparation, the
mobile  phase  was  submitted  to  ultrasonic  bath  for  30
minutes.
Equipment
The HPLC equipment used was model 1525 Waters (Waters
Chromatography  Systems,  CA,  USA),  connected  to  a
Waters 2487 UV/Visible detector and manual injector 7725i
(Rheodyne Breeze, CA, USA).
HPLC Method
HPLC method was carried out in an isocratic mode and the
room temperature was maintained at 25 °C. It was used the
column  Phenomenex  Luna  CN  (250  x  4.60  mm;  5  μm
particle size). The mobile phase was a mixture of water +
0.7 % acetic acid and ethanol (78:22, v/v). The flow rate was
1.3 mL min-1.  The wavelength used was 318 nm, with an
injection  volume  of  20  µL.  The  retention  time  of
secnidazole sample was 4.26 minutes.
Pharmaceutical preparations
Twenty tablets were accurately weighed, crushed into a fine
powder and mixed using a mortar and pestle. A quantity of
tablet  powder  equivalent  to  1.000 mg of  secnidazole  was
weighed accurately into a 25 mL calibrated flask; the diluent
solution was  added and the mixture was  sonicated for  10
min  to  complete  dissolution  of  the  secnidazole;  then  the
mixture was diluted to the mark with the diluent. A portion
of the resulting mixture was withdrawn and filtered through
a 0.45 mm filter to ensure the absence of particulate matter.
The filtrate was appropriately diluted with the diluent before
injection onto the column.
Method Validation
Method  validation  was  performed  according  to  the
parameters  established  in  guidelines  (27-32)  for  linearity,
selectivity,  accuracy,  precision,  robustness,  detection  limit
and quantitation limit.
Linearity
Linearity  was  evaluated  by  regression  analysis.  Sample
solutions (5-100 µg mL-1 secnidazole) were injected onto the
column in triplicate and the chromatograms were recorded.
The equation of the line was determined by linear regression
analysis  by  the  method  of  least  squares.  Data  from  the
analytical curves were statistically analyzed by Analysis of
Variance (ANOVA).
Precision
The  method  precision  was  determined  by  repeatability
precision  (intra-assay)  and  intermediate  (inter-assay).  The
repeatability was performed by the preparation and analysis
of six injections of secnidazole at the concentration of 50 µg
mL-1, on the same day and in the same working conditions.
The inter-assay  was performed on different  days and two
different  analysts;  the  first  was  carried  out  by  the
preparation and analysis of six injections of secnidazole in
concentration of 50 µg mL-1, in three different days and in
the same working  conditions;  the  second was  carried  out
between  analysts  using  the  same  experimental  conditions
but by different analysts. Statistical analyses were performed
using RSD (%) values of each test.
Accuracy
The accuracy  of  the  method was  proved by  the  recovery
assay,  in  which  known  amounts  of  secnidazole  standard
were added to known amounts of secnidazole sample. The
recovery assay was conducted at three different levels R1,
R2 and R3, 80, 100 and 120 %, respectively, according to
ICH  recommendations  (33).
Aliquots  of  5.9,  7.5  and  9.1  mL of  secnidazole  standard
solution  (concentration  of  100  µg  mL-1)  were  added,
separately,  to  aliquots  of  500 µL of the  sample solutions
(concentration  of  100  µg  mL-1),  resulting  in  solutions  of
concentrations 64 (R1), 80 (R2) and 96 (R3) µg mL-1. The
concentration  of  standard  solution  added  to  the  sample
solution  was  recovered  by  area  values  of  the
chromatographic  peak.  The  recovery  was  performed  in
triplicate and the solutions were prepared according to Table
1.
The  recovery  percentage  (R%)  was  calculated  using  the
Equation 1, which is determined by Association of Official
Analytical Chemists (34).
Equation 1: %R = {(Cr - Ca) / Cp} x 100
Where:
Cr = Substance concentration of the standard added sample 
(µg mL-1)
Ca= Concentration of the sample (µg mL-1)
Cp= Theoretical concentration of standard secnidazole 
added (µg mL-1)
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Table 1. Preparation of the secnidazole solutions for the accuracy 











Sample 500 - 5 -
R1 500 5900 64 80
R2 500 7500 80 100
R3 500 9100 96 120
Standard - 500 5 -
a -Volumetric flask of 10 mL; b -Concentration levels prepared in triplicate
Selectivity  
Selectivity was evaluated by a forced degradation procedure.
Secnidazole samples solutions were prepared in 1 x 10-1 mol
L-1 HCl, 1 x 10-1 mol L-1NaOH and 0.3 % H2O2. The neutral
and  photolytic  conditions  were  prepared  using  ultrapure
water  as  solvent.  Alkaline,  acidic  and  oxidative  samples
were  heated  to  60 °C for  6  hours.  Neutral  samples  were
heated for 80 °C also for 6 hours and the photolytic samples
were exposed to ultraviolet  light  (UVC, 254 nm) at  room
temperature  (25  ±  2  °C)  for  6  hours.
Aliquots of these solutions were taken at 1, 3 and 6 h for all
the conditions  and the aliquots were analyzed immediately
by the HPLC method.
Robustness
The robustness was evaluated using Youden & Steiner test
(35).  The  Youden  test  not  only  allows  to  evaluate  the
robustness of the method, but also to order the influence of
each variation on the final results. In this method, 8 assays
are  performed.  The  assays  are  performed  separately  to
determine the effects of variation of 7 different steps (19, 21,
28, 35-37). Table 2 shows the variations performed. Upper
case letters represent normal working conditions and lower
case letters represent small changes. The solutions of 50 μg
mL-1 of secnidazole tablets were used for each assay.
Table 2. Parameter and variations used in the Youden & Steiner
test to evaluate the robustness of the method
Experiments
Conditions Normal Changed 1 2 3 4 5 6 7 8
Wavelenght (nm) 318 320 A A A A a a a a
Ultrasonic time 10 5 B B b b B B b b




78 75 D D d d d d D D
Flow (mL/min-1) 1.3 1.2 E e E e e E e E
Injection volume
(µL) 20 18 F f f F F f f F
Temperature of
room (°C) 24 27 G g g G g G G g
s t u v w x y z
A, B, C, D, E, F, G = normal conditions
a, b, c, d, e, f, g = modified conditions
s = assay using conditions A, B, C, D, E, F and G
t = assay using conditions A, B, c, D, e, f and g
u = assay using conditions A, b, C, d, E, f and g
v = assay using conditions A, b, c, d, e, F and G
w = assay using conditions a, B, C, d, e, F and g
x = assay using conditions a, B, c, d, E, f and G
y = assay using conditions a, b, C, D, e, f and G
z = assay using conditions a, b, c, D, E, F and g
Limits of detection and quantification 
The  limit  of  detection  (LOD)  and  limit  of  quantification
(LOQ) of the method were obtained from Equations 2 and 3:
Equation 2: LOD: 3.3 σ/S
Equation 3: LOQ: 10 σ/S 
Where: 
σ: Standard deviation of the response 
S: Slope of the calibration curve
Results and discussion
Linearity  
A  standard  solution  of  secnidazole  (500  μg  mL-1)  was
appropriately  diluted  with  the  diluent  solution  to  obtain
solutions  in  the  concentration  range  of  5–100  μg  mL-1.
Twenty  microliters  of  each  solution  were  injected  in
triplicate  into  the  column under  the  previously  described
chromatographic  conditions.
The equation of the line, determined by the method of least
squares,  is  y  =  37893x  –  8247.1,  with  a  correlation
coefficient (r) equals to 0.9996 (Figure 2). ANOVA did not
presented  significant  linearity  deviation at  a  5 % level  of
variance  by  presenting  a  calculated  value  F  (0.54)  lower
than the critical value F (3.26).














Figure  1.  Analytical curve of secnidazole at concentrations of 5-
100 μg mL-1 by validated HPLC method.
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Precision
For the precision of the method were evaluated intra-assay
precision  parameters,  inter-days  and  between  analysts  as
showed  in  Tables  3,  4  and  5.
The data showed the suitable precision of the intra-assay,
inter-assay  and between analysts  analysis  (RSD values  of
0.70 %, 0.47 % and 1.96 %, respectively), since all the RSD
values were below the 2 % recommended (38).
Table 3. Determined values for intra-assay precision by HPLC
Peak area RSD(%)
Day
1 2 3 4 5 6
1855429 1827345 1868220 1847020 1871651 1853708 0.86
1853320 1848040 1875380 1879086 1856890 1853073 0.70
1783204 1882428 1888690 1901940 1875390 1895567 2.36
Table 4. Determined values for inter-assay precision by HPLC
Day Areaa SD RSD (%)
1 1853896
2 1860965 8702 0.47
3 1871203
a Average peak area by six determinations
Table 5. Determined values for precision between two analysts by
HPLC
Peak height RSD(%)
1 2 3 4 5 6
Analyst 1 1853320 1848040 1875380 1879086 1856890 1853073
1.96
Analyst 2 1840538 1781699 1808721 1843824 1792307 1793464
Accuracy
The  accuracy  was  performed  by  recovery  through  the
analysis of three concentrations in the pre-established range.
The  results  of  accuracy  are  shown  in  the  Table  6.
The percentage of recovery was 99.58 %, which proves the
accuracy  of  the  method  and  corroborates  with  the  one
recommended by Horwitz and collaborators (39) and AOAC
(34). 















R1 59 58.07 98.42
R2 75 74.73 99.64 99.58 1.14
R3 91 91.63 100.69
Robustness
Robustness was analyzed using the Youden Test. Its premise
is to introduce many changes at once in order to determine
the  effect  of  individual  changes.
In the analysis performed, only one significant effect, from
the  flow  (mL  min-1),  was  observed  in  the  method  when
subjected to the proposed changes because its value (8.44) is
higher  than  the  calculated  effect  value  (7.59),  which  is
represented  by  a  red  line  in  Figure  3.  For  all  other
conditions,  the  method was  considered  robust  because  its
effect values were lower than the calculated (7.59).
Figure 3. Effect of variations by the Youden test to evaluate the
robustness of the method.
Selectivity
Selectivity was evaluated by a forced degradation procedure
or  stress  test.  The  Figure  4  show the  comparison  of  the
chromatograms obtained for secnidazole sample solution in
alkaline  (A),  acidic  (B),  water  (C),  oxidative  (D)  and
photolytic conditions (E). The Figure 5 shows the overlap of
chromatograms of secnidazole standard and sample and the
adjuvants.
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Figure 4. Chromatograms of  the degradations of  secnidazole  in
alkaline (A), acidic (B), neutral (C), oxidative (D) and photolytic
conditions (E).
                     
                        
Figure 5.  Overlap of chromatograms of secnidazole standard and
sample.
The maximum degradation of the drug occurred in alkaline
and oxidative conditions. Under alkaline conditions, the area
of the secnidazole decreased by 69.13 %, showing the great
instability  of  the  drug  under  these  conditions.  Under
oxidative conditions, the reduction in the area was of 83.35
%.  The  secnidazole  did  not  present  degradation  under
neutral, acidic and photolytic conditions. Thus, the drug was
shown to be stable in these conditions.  All of these results
combined to demonstrate that the method, as well as being
selective,  is  indicative  of stability,  because  it  was able to
differentiate  secnidazole  from  the  other  degradation
products.
Content of secnidazole in pharmaceutical tablets
The validated method was applied for the determination of
secnidazole  in  tablets  using  the  line  equation  obtained  in
linearity.  Samples from 1.000 mg secnidazole tablets were
analyzed. The results are in Table 7.
Table 7. Assay of secnidazole in pharmaceutical tablets
Day
Content of secnidazole Average (%) RSD (%)
μg mLg mL-1 %
1 47.54 95.07
96.97 2.442 49.86 99.72
3 48.05 96.10
Analysis  of  the  secnidazole  content  in  tablets  using  the
proposed  method was  96.97  %.  This  result  is  within  the
specification in the official  compendium that recommends
content between 95 to 110 % (40).
Conclusions
A  method  by  reversed-phase  liquid  chromatography  was
developed using mobile phase composed of water + 0.7 %
acetic acid and ethanol (78:22, v/v) in which all validation
parameters were found to be highly satisfactory, including
linearity,  selectivity,  precision,  accuracy,  robustness  and
limit of detection and quantification appropriate.
In the official  compendia and scientific  journals  surveyed
were not found a method using mobile phase with less toxic
solvents for the quantification of secnidazole. Added to this,
this method uses lower amounts of organic solvent, does not
use buffer solution in mobile phase and produces lower level
of  waste.  Then,  it  can  be  considered  an  innovative  and
advantageous method in the application of green analytical
chemistry, being an alternative ecologically correct and safe
to be used in routine analyzes of the quality control.
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